
-
Global film industry reels from Trump tariff announcement
-
Cardinals assemble to elect pope and set course for church
-
Meta content moderator cuts over 2,000 jobs in Spain: union
-
Pakistan conducts second missile test, India readies civil defence drills
-
Pro-EU or pro-Trump? Romania faces decisive choice in vote
-
Nazi surrender site sets the scene for Wim Wenders short film
-
French court backs Olympics choreographer in cyberbullying case
-
Romania run-off pits pro-Trump nationalist against centrist mayor
-
South Africa's Rabada back in IPL after serving drug ban
-
Pride and excitement as UK crowds celebrate 80 years since WWII's end
-
Ex-French interior minister Darmanin apologises for 2022 Champions League fiasco
-
Zhao on brink of becoming China's first World Snooker champion
-
Stars come out for Met Gala, showcasing Black dandyism
-
Jury selection begins in Sean 'Diddy' Combs sex crimes trial
-
Martinez rushing to be ready for Barca showdown, says Inter's Inzaghi
-
Warren Buffett to remain as Berkshire Hathaway board chair
-
UK royals lead celebrations to mark 80 years since WWII end
-
Top Spanish court drops tax complaint against ex-king Juan Carlos
-
Who are the Middle East's Druze religious community?
-
Russian reporter critical of Ukraine war escapes to France
-
France names first Concorde jet a historical monument
-
France, EU take aim at Trump's assault on science, seek to lure US researchers
-
Catholic Church's direction in the balance as vote conclave looms
-
German coalition deal signed on eve of Merz govt launch
-
UK begins four days of events to honour last WWII veterans
-
Cassocks competition: whose outfit will new pope wear?
-
Traditional culture, fancy dress meet at Hong Kong's raucous bun festival
-
Spain foreign tourist numbers break record in early 2025
-
Catholic Church's direction in the balance as conclave looms
-
France, EU leaders take aim at Trump in bid to lure US scientists
-
Olympic 100m medallist Kerley denies battery, admits to 'altercation'
-
Man Utd have 'big responsibility' to win Europa League: Amorim
-
Israel cabinet approves plan for Gaza 'conquest'
-
Alexander-Arnold confirms Liverpool exit after 'hardest decision'
-
Francis's popemobile converted into clinic for Gazan children
-
Spain's blackout highlights renewables' grid challenge
-
Trent Alexander-Arnold announces Liverpool departure
-
Top French chefs warm to AI in the kitchen
-
France, EU leaders spearhead effort to lure US scientists
-
Huthis say US bombed Yemen after strike on Israel's main airport
-
Pakistan conducts second missile test since renewed India standoff
-
Israel cabinet approves plan including Gaza 'conquest'
-
Oil prices slide after OPEC+ output hike
-
Kardashian ready to 'confront' her Paris attackers in court: lawyers
-
Flight club: Pinching pigeons on the India-Pakistan border
-
Trump orders rebuilding and reopening of defunct US prison Alcatraz
-
Jury selection to begin in Sean 'Diddy' Combs sex crimes trial
-
Facing a broken economy, Ghana's tech-savvy teens turn to fraud
-
Trump says ordering '100% tariff' on all movies produced abroad
-
Victorious Australian PM holds 'warm' chat with Trump
RBGPF | 6.26% | 67.21 | $ | |
VOD | -0.23% | 9.588 | $ | |
RYCEF | 0.67% | 10.42 | $ | |
CMSC | -0.09% | 22.08 | $ | |
CMSD | 0.04% | 22.329 | $ | |
SCS | -0.4% | 10.1 | $ | |
RELX | 0.3% | 55.186 | $ | |
RIO | -0.29% | 59.53 | $ | |
BCC | -1.14% | 95.07 | $ | |
JRI | -0.3% | 13.031 | $ | |
BCE | -1.19% | 21.197 | $ | |
GSK | -0.08% | 39.04 | $ | |
AZN | -0.42% | 72.14 | $ | |
BP | 2.73% | 28.91 | $ | |
BTI | 1.3% | 43.74 | $ | |
NGG | 0.06% | 71.724 | $ |

Exousia Pro Issues Update on Name Change
ORLANDO, FLORIDA / ACCESS Newswire / April 3, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other diseases, is pleased to announce that the Company has received comments from FINRA regarding the name change.
FINRA has requested specific Board minutes and the stamped Articles of Amendment from the State of Florida showing the name change from Marijuana, Inc. to Exousia Pro, Inc.
We submitted the Articles of Amendment to the filer yesterday, and they will be forwarded to the State this morning. To facilitate the Name change, the name of our subsidiary had to be changed from Exousia Pro, Inc. to Exousia AI, Inc., to release the name for the parent company.
"This is a positive indicator that the process is moving along, as evidenced by hearing from FINRA within the first 30 days of the filing," said Matthew Dwyer, President of Exousia Pro, Inc.
About us
Exousia Pro is a clinical-stage biotechnology company developing new ways to exploit the therapeutic potential of exosomes, initially focused on oncology. The company's patented manufacturing process utilizes plant-based materials to create exosomes used in a number of commercial applications from dermatology to dentistry. The company's proprietary loading technology can infuse a range of molecules from drugs to DNA.
For more information, please visit: www.exousiapro.com
SAFE HARBOR
Forward-looking statements in this release are made under the "safe harbor" provision of the Private Securities Litigation Reform Act of 1995. Ludwig Enterprises Inc.'s forward-looking statements do not guarantee future performance. This news release includes forward-looking statements concerning the future level of business for the parties. These statements are necessarily subject to risk and uncertainty. Actual results could differ materially from those projected in these forward-looking statements due to certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of Ludwig Enterprises, Inc., and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, appropriately price, retain, and complete projects and changes in products and competition.
CONTACT:
Marijuana, Inc.
www.Exousiapro.com
Twitter: @Exousia_Pro
Investor Relations
[email protected]
SOURCE: Marijuana Inc.
View the original press release on ACCESS Newswire
P.Santos--AMWN